https://www.marketscreener.com/quote/stock/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-announces-licensing-of-a-novel-first-in-class-antifungal-program-from-Fox-Chase-Chemical-Div-40161861/?utm_source=telegram&utm_medium=social&utm_campaign=share